In a pretrial proceeding AstraZeneca's attorneys
tried to convince Judge Joseph Slights III to throw out testimony from
pharmacology expert witnesses who connected Seroquel drug use to diabetes. Attorneys
and plaintiffs are now watching to see how Slights will rule. A win for
AstraZeneca could avert a trial scheduled to start June 29.
The case was brought by Kansas resident Nina Scaife, 46, who started taking Seroquel in May 2003 and was diagnosed with diabetes a year later, according to testimony. AstraZeneca, which has said that it will litigate each Seroquel case on its individual merits, argued that Scaife's expert witnesses failed to examine the scientific issues rigorously enough to satisfy legal requirements.
The case was brought by Kansas resident Nina Scaife, 46, who started taking Seroquel in May 2003 and was diagnosed with diabetes a year later, according to testimony. AstraZeneca, which has said that it will litigate each Seroquel case on its individual merits, argued that Scaife's expert witnesses failed to examine the scientific issues rigorously enough to satisfy legal requirements.
Leave a comment